(Q44335976)

2 December 2017

Antinociceptive effects of the kappa opioid, U50,488: lack of modulation by 5-HT2 antagonists (English)

1 reference

2 December 2017

0 references

L A Dykstra

1

1 reference

PubMed ID

7870999

2 December 2017

K R Powell

series ordinal

2

1 reference

PubMed ID

7870999

2 December 2017

Y P Lin

series ordinal

3

1 reference

2 December 2017

1 January 1993

1 reference

2 December 2017

1 reference

2 December 2017

112

1 reference

2 December 2017

1

1 reference

2 December 2017

116-120

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02247371

2 December 2017

0 references

cites work

Evaluation of the interactions of serotonergic and adrenergic drugs with mu, delta, and kappa opioid binding sites

1 reference

12 December 2020

Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists

1 reference

12 December 2020

Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output

1 reference

12 December 2020

Apparent antinociceptive properties of piperazine-type serotonin agonists: trifluoromethylphenylpiperazine, chlorophenylpiperazine, and MK-212.

1 reference

12 December 2020

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist

1 reference

12 December 2020

Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys

1 reference

12 December 2020

Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey

1 reference

12 December 2020

U-50,488, a selective kappa opioid agonist: Comparison to other reputed kappa agonists

1 reference

12 December 2020

The concept of selectivity in 5-HT receptor research

1 reference

12 December 2020

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1 reference

12 December 2020

Kappa opioid analgesia is dependent on serotonergic mechanisms

1 reference

12 December 2020

Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands

1 reference

12 December 2020

Selective effects of pirenperone on analgesia produced by morphine or electrical stimulation at sites in the nucleus raphe magnus and periaqueductal gray.

1 reference

12 December 2020

In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.

1 reference

12 December 2020

Mu and delta opioid receptors inhibit serotonin release in rat hippocampus

1 reference

12 December 2020

Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli

1 reference

12 December 2020

Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule

1 reference

12 December 2020

Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test

1 reference

12 December 2020

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

1 reference

12 December 2020

Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse

1 reference

12 December 2020

A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.

1 reference

12 December 2020

Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey

1 reference

12 December 2020

Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.

1 reference

12 December 2020

Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice

1 reference

12 December 2020

A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

1 reference

12 December 2020

Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.

1 reference

12 December 2020

Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects

1 reference

12 December 2020

Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.

1 reference

12 December 2020

Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02247371

1 reference

2 December 2017

1 reference

PubMed ID

7870999